Survival outcome of patients with screening versus symptomatically detected colorectal cancers

Colorectal Disease

Volumn 15, Issue 1, 2013, Pages 74-79

  Pande, R ^a   Froggatt, P ^a   Baragwanath, P ^a   Harmston, C ^a  

^a UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

Colorectal neoplasms; Early detection of cancer; Mass screening; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL;

AGED; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; FEMALE; GREAT BRITAIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE;

EID: 84871653823     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.03120.x     Document Type: Article

References (15)

1. Mandel JS. Screening for colorectal cancer. Gastroenterol Clin North Am 2008; 37: 97-115.
2. O'Morain CA, Van Cutsem E, Spicak J et al. European initiatives in colorectal cancer screening. Eur J Gastroenterol Hepatol 2011; 23: 201-3.
3. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
4. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
5. Kronborg O, Jorgensen OD, Fenger C et al. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39: 846-51.
6. Hewitson P, Glasziou P, Irwig L et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; CD001216.
7. Group UKCCSP. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004; 329: 133.
8. Weller D, Coleman D, Robertson R et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007; 97: 1601-5.
9. Scholefield JH, Moss SM, Mangham CM et al. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012; 61: 1036-40.
10. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13years and seven biennial screening rounds. Gut 2002; 50: 29-32.
11. Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?Br J Cancer 2009; 101(Suppl 2): S102-9.
12. Harmston C, Hunter J, Wong L. Does the location of screen-detected cancers differ from that seen in the unscreened population?Colorectal Dis 2010; 12: 324-6.
13. Bharathan B, Welfare M, Borowski DW et al. Impact of deprivation on short- and long-term outcomes after colorectal cancer surgery. Br J Surg 2011; 98: 854-65.
14. MacDonald AJ, McEwan H, McCabe M et al. Age at death of patients with colorectal cancer and the effect of lead-time bias on survival in elective vs emergency surgery. Colorectal Dis 2011; 13: 519-25.
15. Fisher R, Rooney PS. Faecal occult blood testing in areas of high incidence and mortality; the effect of screening the population aged 50 to 59. Colorectal Dis 2011; 13: 1024-9.